MedicaidCoverageLow impact
MMP 23-43: Revisions to High Frequency Chest Wall Oscillating (HFCWO) Device and Accessories Policy
Michigan Medicaid - MDHHS·MI · Pulmonology, Neurology, PM&R (Physical Medicine & Rehab)·Medical Policy
Effective date
Aug 1, 2023
We identified it
Jun 20, 2026
Summary
Michigan Medicaid revised the High Frequency Chest Wall Oscillating (HFCWO) device policy to specify coverage criteria, documentation requirements, and prior authorization rules. Coverage is limited to 4 months initially for specific conditions like cystic fibrosis, bronchiectasis, and neuromuscular disorders affecting secretion mobilization.
Action Required
By August 1, 2023: Billing team must verify HFCWO device claims meet new coverage criteria (cystic fibrosis, confirmed bronchiectasis, or neuromuscular disorders). Obtain prior authorization for all conditions except cystic fibrosis. Ensure documentation is from neurology, PM&R, or pulmonology specialists and is less than 180 days old. Maintain equipment use logs for continuation beyond 4 months. Claims not meeting criteria will be denied.